GESSEL Attorneys at Law is lauded for its ‘unmatched expertise in the area of Polish capital markets regulations’. IPO, SPF, FPO, and public offering mandates are also all within the strong capabilities of the team, which predominately advises Polish public companies, investment banks, and brokerage houses. Leszek Koziorowski and Krzysztof Marczuk jointly chair the department, and they are ably supported by senior associate Michał Wieliński, who is praised for his ’deep understanding of the legal framework governing various types of Polish capital markets transactions’.
Testimonials
Collated independently by Legal 500 research team.
'Our experience with this law firm has been nothing short of outstanding. What makes their team unique is their unmatched expertise in the area of Polish capital markets regulations, coupled with their strong understanding of the biotech/pharma and medtech sectors.'
‘Krzysztof Marczuk and Magdalena Szeplik are definitely individuals that stand out. They are very knowledgeable in capital markets and extremely responsive; working with them is pure pleasure as I don't have to worry about legal matters and can 100% focus on other aspects being very confident that they will take care of everything with minimum involvement from my side.'
- 'Prospective clients will undoubtedly find the team appealing to work with. They not only have a deep understanding of capital markets regulations and know how to communicate effectively with the local financial supervision authority, but they also possess practical knowledge of the operation and risks facing life sciences companies.'
- 'Their track record of successful transactions speaks volumes about their capabilities. They combine their legal expertise with a business-oriented mindset, ensuring that their clients' transactional goals are met. When it comes to innovations this practice has excelled in carefully selecting individuals with a unique blend of expertise to handle each transaction and project, thus enhancing the quality and speed of their services.'
- 'We strongly recommend this law firm to anyone seeking expertise in capital markets transactions, especially within the life sciences sector. Their unique blend of knowledge, client-centered approach, and commitment to excellence make them an exceptional choice in the legal field.’
- 'What makes Michał Wieliński stand out is his deep understanding of the legal framework governing various types of Polish capital markets transactions. Michał not only possesses a robust understanding of relevant regulations and case law, but his capacity to analyse and address complex legal challenges has led to the development of sound legal strategies that ensured the success of numerous transactions and negotiations.'
- 'Krzysztof Marczuk distinguishes himself through his extensive expertise in ECM, DCM and M&A transactions, including IPOs and SPOs. His expertise spans commercial law, corporate governance, and regulatory compliance. He is a trusted advisor in divestments, acquisitions and MAR-related matters.'
‘An exceptionally dedicated team, fully professionals with business acumen. They do not inflate working hours, do not invoice undue amounts, and do not impose unwanted and unnecessary services.’
Key clients
- Cavatina Holding S.A.
- DataWalk S.A.
- Medicalgorithmics S.A.
- Urteste S.A.
- Suwary S.A
- Pure Biologics S.A.
- Bioceltix S.A.
- Genomtec S.A.
- Caspar Asset Management S.A.
- Kredyt Inkaso S.A.
- Polski Fundusz Rozwoju
- ExpertSender S.A.
- ONDE S.A.
- Vercom S.A.
- WPD Pharmaceuticals S.A
Work highlights
- Advised Cavatina Holding S.A. on two separate bond issue programmes with a total value of PLN350m.
- Advised Urteste S.A. on IPO processes.
- Advised Pure Biologics S.A. on a public offer.
Practice head
The lawyer(s) leading their teams.
Leszek Koziorowski, Krzysztof Marczuk